Successful meropenem therapy of a brain abscess and meningitis arising from acute purulent otomastoiditis: Case report

Journal of Chemotherapy

Volumn 10, Issue 2, 1998, Pages 132-135

  Paffetti, A ^a,b   D'Aviera, L ^a   Foche, F L E ^a   Mannozzi, P ^a   Mastropietro, C ^a   Croce, G F ^a   Ferretti, G ^a   Rossi, F ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b NONE   (Italy)

Author keywords

Brain abscess; Meningitis; Meropenem; Otomastoiditis

Indexed keywords

MEROPENEM; METHYLPREDNISOLONE; TEICOPLANIN;

ADULT; ARTICLE; BACTERIUM ISOLATION; BRAIN ABSCESS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MASTOIDITIS; MENINGITIS; STAPHYLOCOCCUS AUREUS;

EID: 0031943214     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.1998.10.2.132     Document Type: Article

References (15)

1. Bradley PJ, Shaw MDM. Three decades of brain abscess in Merseyside. J R Coll Surg Edinburgh 1983: 28: 223-228.
2. Wispelwey B, Scheld WM. Brain abscess. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 4th ed. New York, Churchill Livingstone, 1995: 887-900.
3. Yang S-Y. Brain abscesses: a review of 400 cases. J Neurosurg 1981; 55: 794-799.
4. Mampalam T, Rosenblum M. Trends in the management of bacterial brain abscesses: a review of 102 cases over 17 years. Neurosurgery 1988; 23: 451-458.
5. Seydoux C, Francioli P. Bacterial brain abscesses: factors influencing mortality and sequelae. Clin Infect Dis 1992: 15: 394-401.
6. Tekkok IH, Erbengi A. Management of brain abscess in children: a review of 130 cases over a period of 21 years. Childs Nerv Syst 1992; 8: 411-416.
7. Osenbach RK, Loftus CM. Diagnosis and management of brain abscess. Neurosurg Clin North Am 1996; 3: 403-420.
8. Akova M. Brain abscesses: current treatment options. CNS Drugs 1996; 6: 358-366.
9. Meis JFG, Groot-Loonen J, Hoogkamp-Korstanje JAA. A brain abscess due to multiply-resistant Enterobacter cloacae successfully treated with meropenem. Clin Infect Dis 1995; 20: 1567.
10. Schmutzhard E, Williams KJ, Vukmirovits G, et al. A randomised comparison of meropenem with cefotaxime or ceftriaxone for the treatment of bacterial meningitis in adults. J Antimicrob Chemother 1995; 36 (suppl A): 85-97.
11. Klugman KP, Dagan R, The Meropenem Meningitis Study Group. Randomised comparison of meropenem with cefotaxime for treatment of bacterial meningitis. Antimicrob Agents Chemother 1995; 39: 1140-1146.
12. Norrby SR, Newell PA, Faulkner KL, Lesky W. Safety profile of meropenem: international clinical experience based on the first 3125 patients treated with meropenem. J Antimicrob Chemother 1995; 36 (suppl A): 207-223.
13. Calandra G, Lydick E, Carrigan J, Weiss L, Guess H. Factors predisposing to seizures in seriously ill infected patients receiving antibiotics: experience with imipenem/cilastatin. Am J Med 1988; 84: 911-918.
14. Wong VK, Wright HT, Ross LA, Mason WH, Inderlied CB, Kim KS. Imipenem/cilastatin treatment of bacterial meningitis in children. Pediatr Infect Dis J 1991; 10: 122-125.
15. Asensi J. Therapy of brain abscess with imipenem - a safe therapeutic choice? J Antimicrob Chemother 1996; 37: 200-203.